| Package | silth.fhir.terminology.core |
| Type | CodeSystem |
| Id | Id |
| FHIR Version | R5 |
| Source | https://terms.sil-th.org/core/https://terms.sil-th.org/core/STU1/CodeSystem-cs-thcc-allergy-manifest.html |
| Url | https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest |
| Version | 0.1.2 |
| Status | active |
| Date | 2023-10-11T23:15:12+07:00 |
| Name | CS_THCC_AllergyManifest |
| Title | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
| Experimental | False |
| Description | รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68) |
| Content | complete |
| ValueSet | |
vs-thcc-allergy-manifest  | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
No resources found
Note: links and images are rebased to the (stated) source
This case-insensitive code system https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest defines the following codes:
FHIR{
"resourceType" : "CodeSystem",
"id" : "cs-thcc-allergy-manifest",
"meta" : {
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">01<a name=\"cs-thcc-allergy-manifest-01\"> </a></td><td>D59.0</td><td>Drug-induced autoimmune hemolytic anemia</td></tr><tr><td style=\"white-space:nowrap\">02<a name=\"cs-thcc-allergy-manifest-02\"> </a></td><td>D59.2</td><td>Drug-induced non autoimmune hemolytic anemia</td></tr><tr><td style=\"white-space:nowrap\">03<a name=\"cs-thcc-allergy-manifest-03\"> </a></td><td>D60.1</td><td>Transient acquired pure red cell aplasic</td></tr><tr><td style=\"white-space:nowrap\">04<a name=\"cs-thcc-allergy-manifest-04\"> </a></td><td>D61.1</td><td>Drug-induced aplastic anemia</td></tr><tr><td style=\"white-space:nowrap\">05<a name=\"cs-thcc-allergy-manifest-05\"> </a></td><td>D64.2</td><td>Secondary sideroblastic anemia due to drugs and toxic</td></tr><tr><td style=\"white-space:nowrap\">06<a name=\"cs-thcc-allergy-manifest-06\"> </a></td><td>D68.3</td><td>Haemorrhagic disorders due to circulating anticoagulants</td></tr><tr><td style=\"white-space:nowrap\">07<a name=\"cs-thcc-allergy-manifest-07\"> </a></td><td>D70</td><td>Agranolocytosis</td></tr><tr><td style=\"white-space:nowrap\">08<a name=\"cs-thcc-allergy-manifest-08\"> </a></td><td>G21.0</td><td>Malignant neuroleptic syndrome</td></tr><tr><td style=\"white-space:nowrap\">09<a name=\"cs-thcc-allergy-manifest-09\"> </a></td><td>G21.1</td><td>Other drugs-induced secondary parkinsonism</td></tr><tr><td style=\"white-space:nowrap\">10<a name=\"cs-thcc-allergy-manifest-10\"> </a></td><td>G25.1</td><td>Drug-induced tremor</td></tr><tr><td style=\"white-space:nowrap\">11<a name=\"cs-thcc-allergy-manifest-11\"> </a></td><td>G25.6</td><td>Drug-induced tremor and other tias of organic crign</td></tr><tr><td style=\"white-space:nowrap\">12<a name=\"cs-thcc-allergy-manifest-12\"> </a></td><td>G44.4</td><td>Drugs - induced headocin, not elsewhere</td></tr><tr><td style=\"white-space:nowrap\">13<a name=\"cs-thcc-allergy-manifest-13\"> </a></td><td>G72.0</td><td>Drugs - induced myopathy classified</td></tr><tr><td style=\"white-space:nowrap\">14<a name=\"cs-thcc-allergy-manifest-14\"> </a></td><td>G93</td><td>Toxic encephalopathy</td></tr><tr><td style=\"white-space:nowrap\">15<a name=\"cs-thcc-allergy-manifest-15\"> </a></td><td>H40.6</td><td>glaucon secondary to drugs</td></tr><tr><td style=\"white-space:nowrap\">16<a name=\"cs-thcc-allergy-manifest-16\"> </a></td><td>H26.3</td><td>Drug-induced catarat</td></tr><tr><td style=\"white-space:nowrap\">17<a name=\"cs-thcc-allergy-manifest-17\"> </a></td><td>I42.7</td><td>Cardiomyopathy due to drugs and other external drugs</td></tr><tr><td style=\"white-space:nowrap\">18<a name=\"cs-thcc-allergy-manifest-18\"> </a></td><td>I95.2</td><td>Hypotension due to drugs</td></tr><tr><td style=\"white-space:nowrap\">19<a name=\"cs-thcc-allergy-manifest-19\"> </a></td><td>L23.3</td><td>Allergic contact dermatitis due to drugs in contact With skin</td></tr><tr><td style=\"white-space:nowrap\">20<a name=\"cs-thcc-allergy-manifest-20\"> </a></td><td>L24.4</td><td>Irritant contact dermatitis due to drugs in contact with skin</td></tr><tr><td style=\"white-space:nowrap\">21<a name=\"cs-thcc-allergy-manifest-21\"> </a></td><td>L25.1</td><td>Unspecified contact dermatitis due to drugs in contact with skin</td></tr><tr><td style=\"white-space:nowrap\">22<a name=\"cs-thcc-allergy-manifest-22\"> </a></td><td>L26</td><td>Exfoliative dermatitis</td></tr><tr><td style=\"white-space:nowrap\">23<a name=\"cs-thcc-allergy-manifest-23\"> </a></td><td>L27.0</td><td>Generalized skin eruption due to drugs and medicaments</td></tr><tr><td style=\"white-space:nowrap\">24<a name=\"cs-thcc-allergy-manifest-24\"> </a></td><td>L27.10</td><td>Fixed drugs eruption</td></tr><tr><td style=\"white-space:nowrap\">25<a name=\"cs-thcc-allergy-manifest-25\"> </a></td><td>L27.18</td><td>Other specified localized skin eruption due to drugs and medicaments</td></tr><tr><td style=\"white-space:nowrap\">26<a name=\"cs-thcc-allergy-manifest-26\"> </a></td><td>L27.19</td><td>Localized skin eruption due to drugs and medicaments, unspecified</td></tr><tr><td style=\"white-space:nowrap\">27<a name=\"cs-thcc-allergy-manifest-27\"> </a></td><td>L50.0</td><td>Allergic urticaria</td></tr><tr><td style=\"white-space:nowrap\">28<a name=\"cs-thcc-allergy-manifest-28\"> </a></td><td>L50.6</td><td>Contact urticaria</td></tr><tr><td style=\"white-space:nowrap\">29<a name=\"cs-thcc-allergy-manifest-29\"> </a></td><td>L51.0</td><td>Nombullous erythema multiforne</td></tr><tr><td style=\"white-space:nowrap\">30<a name=\"cs-thcc-allergy-manifest-30\"> </a></td><td>L51.1</td><td>Bullous erythema multiforme</td></tr><tr><td style=\"white-space:nowrap\">31<a name=\"cs-thcc-allergy-manifest-31\"> </a></td><td>L51.8</td><td>Other erythema multifonme</td></tr><tr><td style=\"white-space:nowrap\">32<a name=\"cs-thcc-allergy-manifest-32\"> </a></td><td>L51.9</td><td>Erythema multiforme, unspecified</td></tr><tr><td style=\"white-space:nowrap\">33<a name=\"cs-thcc-allergy-manifest-33\"> </a></td><td>M10.2</td><td>Drug-induced gout</td></tr><tr><td style=\"white-space:nowrap\">34<a name=\"cs-thcc-allergy-manifest-34\"> </a></td><td>M62.8</td><td>Rhabdornylysis</td></tr><tr><td style=\"white-space:nowrap\">35<a name=\"cs-thcc-allergy-manifest-35\"> </a></td><td>M80.4</td><td>Drug-induced osteoporosis with pathological factors</td></tr><tr><td style=\"white-space:nowrap\">36<a name=\"cs-thcc-allergy-manifest-36\"> </a></td><td>M81.4</td><td>Drug-induced osteoporosis</td></tr><tr><td style=\"white-space:nowrap\">37<a name=\"cs-thcc-allergy-manifest-37\"> </a></td><td>N14.0</td><td>Analgesic nephropatic</td></tr><tr><td style=\"white-space:nowrap\">38<a name=\"cs-thcc-allergy-manifest-38\"> </a></td><td>N14.1</td><td>Nephropathy induced by other drugs, medicaments and biological substuces</td></tr><tr><td style=\"white-space:nowrap\">39<a name=\"cs-thcc-allergy-manifest-39\"> </a></td><td>N14.2</td><td>toxic nephropathy, not elsewhere classified</td></tr></table></div>"
},
"url" : "https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest",
"version" : "0.1.2",
"name" : "CS_THCC_AllergyManifest",
"title" : "THCC: รหัสลักษณะอาการแพ้ยาที่พบ",
"status" : "active",
"experimental" : false,
"date" : "2023-10-11T23:15:12+07:00",
"publisher" : "Standards and Interoperability Lab - Thailand (SIL-TH)",
"contact" : [
{
"name" : "Standards and Interoperability Lab - Thailand (SIL-TH)",
"telecom" : [
{
"system" : "url",
"value" : "https://www.sil-th.org"
}
]
}
],
"description" : "รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68)",
"caseSensitive" : false,
"content" : "complete",
"count" : 39,
"concept" : [
{
"code" : "01",
"display" : "D59.0",
"definition" : "Drug-induced autoimmune hemolytic anemia"
},
{
"code" : "02",
"display" : "D59.2",
"definition" : "Drug-induced non autoimmune hemolytic anemia"
},
{
"code" : "03",
"display" : "D60.1",
"definition" : "Transient acquired pure red cell aplasic"
},
{
"code" : "04",
"display" : "D61.1",
"definition" : "Drug-induced aplastic anemia"
},
{
"code" : "05",
"display" : "D64.2",
"definition" : "Secondary sideroblastic anemia due to drugs and toxic"
},
{
"code" : "06",
"display" : "D68.3",
"definition" : "Haemorrhagic disorders due to circulating anticoagulants"
},
{
"code" : "07",
"display" : "D70",
"definition" : "Agranolocytosis"
},
{
"code" : "08",
"display" : "G21.0",
"definition" : "Malignant neuroleptic syndrome"
},
{
"code" : "09",
"display" : "G21.1",
"definition" : "Other drugs-induced secondary parkinsonism"
},
{
"code" : "10",
"display" : "G25.1",
"definition" : "Drug-induced tremor"
},
{
"code" : "11",
"display" : "G25.6",
"definition" : "Drug-induced tremor and other tias of organic crign"
},
{
"code" : "12",
"display" : "G44.4",
"definition" : "Drugs - induced headocin, not elsewhere"
},
{
"code" : "13",
"display" : "G72.0",
"definition" : "Drugs - induced myopathy classified"
},
{
"code" : "14",
"display" : "G93",
"definition" : "Toxic encephalopathy"
},
{
"code" : "15",
"display" : "H40.6",
"definition" : "glaucon secondary to drugs"
},
{
"code" : "16",
"display" : "H26.3",
"definition" : "Drug-induced catarat"
},
{
"code" : "17",
"display" : "I42.7",
"definition" : "Cardiomyopathy due to drugs and other external drugs"
},
{
"code" : "18",
"display" : "I95.2",
"definition" : "Hypotension due to drugs"
},
{
"code" : "19",
"display" : "L23.3",
"definition" : "Allergic contact dermatitis due to drugs in contact With skin"
},
{
"code" : "20",
"display" : "L24.4",
"definition" : "Irritant contact dermatitis due to drugs in contact with skin"
},
{
"code" : "21",
"display" : "L25.1",
"definition" : "Unspecified contact dermatitis due to drugs in contact with skin"
},
{
"code" : "22",
"display" : "L26",
"definition" : "Exfoliative dermatitis"
},
{
"code" : "23",
"display" : "L27.0",
"definition" : "Generalized skin eruption due to drugs and medicaments"
},
{
"code" : "24",
"display" : "L27.10",
"definition" : "Fixed drugs eruption"
},
{
"code" : "25",
"display" : "L27.18",
"definition" : "Other specified localized skin eruption due to drugs and medicaments"
},
{
"code" : "26",
"display" : "L27.19",
"definition" : "Localized skin eruption due to drugs and medicaments, unspecified"
},
{
"code" : "27",
"display" : "L50.0",
"definition" : "Allergic urticaria"
},
{
"code" : "28",
"display" : "L50.6",
"definition" : "Contact urticaria"
},
{
"code" : "29",
"display" : "L51.0",
"definition" : "Nombullous erythema multiforne"
},
{
"code" : "30",
"display" : "L51.1",
"definition" : "Bullous erythema multiforme"
},
{
"code" : "31",
"display" : "L51.8",
"definition" : "Other erythema multifonme"
},
{
"code" : "32",
"display" : "L51.9",
"definition" : "Erythema multiforme, unspecified"
},
{
"code" : "33",
"display" : "M10.2",
"definition" : "Drug-induced gout"
},
{
"code" : "34",
"display" : "M62.8",
"definition" : "Rhabdornylysis"
},
{
"code" : "35",
"display" : "M80.4",
"definition" : "Drug-induced osteoporosis with pathological factors"
},
{
"code" : "36",
"display" : "M81.4",
"definition" : "Drug-induced osteoporosis"
},
{
"code" : "37",
"display" : "N14.0",
"definition" : "Analgesic nephropatic"
},
{
"code" : "38",
"display" : "N14.1",
"definition" : "Nephropathy induced by other drugs, medicaments and biological substuces"
},
{
"code" : "39",
"display" : "N14.2",
"definition" : "toxic nephropathy, not elsewhere classified"
}
]
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.